Vanberra Signal

atEM

Curated by Signal

Developer of a computational drug designing platform using cryo EM based technology

Overview

atEM develops a computational drug designing platform using cryo-EM (Cryo-Electron Microscopy) based technology. The company's technology creates 3D structures of drug molecules and finds drug targets. It helps in computational identification and optimization of small-molecule drugs.

Key facts

Founded
2019
Headquarters
Berlin, Germany

Business model

Contact

Open roles

1 role
  • Wissenschaftlicher Mitarbeiter (m/w/d) für wachsendes Start-up

    Remscheid, North Rhine-Westphalia, Germany · On-site · Full-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of an digital infrastructure platform for laboratories

    Health TechnologyMunich, Germany
  • Blockchain game platform offering a ride-to-earn health and fitness DAPP

    Health TechnologyBerlin, Germany
  • EHR management tool for healthcare professionals

    Health TechnologyMannheim, Germany

About atEM

What does atEM do?

atEM develops a computational drug designing platform using cryo-EM (Cryo-Electron Microscopy) based technology.

Where is atEM headquartered?

atEM is headquartered in Berlin, Germany.

When was atEM founded?

atEM was founded in 2019.

Which sector is atEM in?

atEM operates in Health Technology.

Who are atEM's competitors?

Companies similar to atEM include UniteLabs, BikeRush, and EHRbase.

Is atEM hiring?

Yes. atEM has 1 open role listed on Vanberra Signal.